The present invention relates to the use of MPO inhibitors for the treatment of multiple system atrophy. The present invention also relates to the use of MPO inhibitors for the treatment of Huntington's disease. The present invention also relates to the use of MPO inhibitors for neuroprotection.

 
Web www.patentalert.com

< Pyrrolo Pyrimidines as Agents for the Inhibition of Cystein Proteases

> N-[1,3,4]-THIADIAZOL-2-YL-BENZENE SULFONAMIDES, PHARMACEUTICAL COMPOSITIONS THEREOF AND METHODS FOR THEIR THERAPEUTIC USE

> Benzimidazole Derivative and Use as Angiotensin II Antagonist
~ 00502